As a strategic Advisor, Jeff is responsible for working with clients to identify their sustainable competitive advantage and deeply understanding their value proposition. Jeff joined the firm as a Strategic Advisor for the Life Sciences sector.  Jeff is currently President of Biotech Design LLC, a bioprocess engineering consultancy.  Previously he was with Merck & Co., Inc., where he was New Technology Lead and Director, of Global Engineering Solutions, responsible for the assessment of new manufacturing technology for Merck's vaccine, biologics, and sterile manufacturing processes.   He co-led SUN - Merck's Single Use Technology initiative, and the Process Technology Innovation Community of Practice.   Prior roles at Merck include Director of BioProcess Engineering, responsible for business case and concept development for new vaccine and biologics capital projects, Director of Network Management for Therapeutic Protein Commercialization, and the Technology Transfer Team Leader for Gardasil.  Prior to Merck, he worked for Genzyme Corporation, Raytheon Engineers, Koch Engineering, and ARCO Chemical Co.  

He holds a BS in Chemical Engineering from the University of Rochester, an MS in Chemical Engineering from the University of Pennsylvania, and a Certificate in Biotechnology from Tufts University.